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Genomic stability is critical for normal cellular function and its deregulation is a universal
hallmark of cancer. Here we outline a previously undescribed role of COMMD4 in
maintaining genomic stability, by regulation of chromatin remodelling at sites of DNA
double-strand breaks. At break-sites, COMMD4 binds to and protects histone H2B
from monoubiquitination by RNF20/RNF40. DNA damage-induced phosphorylation of the
H2A-H2B heterodimer disrupts the dimer allowing COMMD4 to preferentially bind H2A.
Displacement of COMMD4 from H2B allows RNF20/40 to monoubiquitinate H2B and for
remodelling of the break-site. Consistent with this critical function, COMMD4-deficient cells
show excessive elongation of remodelled chromatin and failure of both non-homologous-
end-joining and homologous recombination. We present peptide-mapping and mutagenesis
data for the potential molecular mechanisms governing COMMD4-mediated chromatin
regulation at DNA double-strand breaks.
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Our cells encounter thousands of DNA damaging eventseach day. If left unrepaired, this damage can lead togenomic instability or malignant transformation1,2. DNA
double-strand breaks (DSBs) are amongst the most toxic lesions
to cells, as their incorrect repair can lead to chromosomal frag-
mentation and cell death2–4. Cells repair DSBs by two major
pathways: non-homologous end-joining (NHEJ) and homologous
recombination (HR). NHEJ re-joins broken DNA ends without
the use of extensive homology and is often regarded as being
error-prone. In contrast, HR repairs DSBs with high fidelity,
although as it requires a sister chromatid for a repair template, it
can only be used during the S and G2 cell cycle phases1,5,6.
Regardless of the repair pathway, the chromatin surrounding the
break-site must be remodelled to allow access of DNA repair
proteins7,8.
Chromatin remodelling plays an essential role in the functioning
of all cellular processes involving DNA, including transcription,
DNA replication and DNA repair and involves the concerted action
of histone post-translational modifications, including, phosphor-
ylation, methylation, acetylation and ubiquitination9. Such respon-
ses upon the induction of DNA DSBs include the phosphorylation
and ubiquitination of H2AX, as well as the ubiquitination of H2A
by RNF8 and RNF168. These chromatin modifications function to
recruit DNA repair proteins to the sites of DSBs and to initiate the
DNA damage response, resulting in altered transcriptional and
translational regulation, as well as activation of cellular checkpoints
and DSB repair10–12.
Copper metabolism gene MURR1 (COMM) domain proteins
are a family of interacting partners of COMMD1 (MURR1).
All ten COMMD family members are highly conserved in
multicellular eukaryotic organisms and are characterised by a
carboxyl-terminal COMM domain that functions as an interface
for protein–protein interactions13. While predicted to function
in copper metabolism, the precise functional role(s) of most
family members has not been fully elucidated. COMMD1 is the
most extensively characterised COMMD protein and is a pleio-
tropic factor, regulating many biological processes, including
copper and cholesterol homoeostasis, ionic transport, protein
aggregation, protein trafficking, oncogenesis, and oxidative
stress14. Futhermore, COMMD1 was recently shown to function
in the repair of DSBs and be a potential therapeutic target for the
treatment of non-small cell lung cancer15. COMMD4, the subject
of this study, has been previously shown to control NFkB activity
in mammals16, to interact with cullins and modulate the activity
of cullin-RING E3 ubiquitin ligase complexes17 and be a good
prognostic marker and therapeutic target in non-small cell lung
cancer18. The authors demonstrated that depletion of COMMD4
in non-small lung cancer patient cell lines impaired proliferation
of these cells and resulted mitotic catastrophe and cancer cell
death18.
Here, we report a role for COMMD4 in maintaining genomic
stability. COMMD4-deficient cells are genomically unstable,
hypersensitive to DNA damaging agents and are unable to effi-
ciently repair DSBs. Our data demonstrates a specific role for
COMMD4 in regulating the monoubiquitination of H2B at sites
of DNA DSBs, by binding to the histone H2A-H2B dimer.
Results
COMMD4 is required for cell survival following exposure to
DNA damaging agents. Using connectivity mapping19, we
identified that the transcript of COMMD4 was co-regulated
with that of the DNA repair protein, human single-stranded
DNA-binding protein 1 (hSSB1) (p < 0.05). We focused on
COMMD4 as it was the top-ranking protein with an unknown
functional role.
The function of hSSB1 is critical for genome stability,
functioning in the repair of DSBs by HR20–22. To explore if
COMMD4 functions similarly, we used an esiRNA and three
different siRNA sequences to deplete COMMD4 from cells
(Supplementary Figs. 1a and 11a); we then treated these cells
with DNA damaging agents. Cells depleted of COMMD4
exhibited increased sensitivity to DNA damaging agents
(Fig. 1a, b). We used three different siRNA sequences to
discount siRNA off-target-effects and rescued the sensitivity to
one of the siRNA sequences (siRNA #2) by transient expression
of siRNA-resistant COMMD4 (Supplementary Figs. 1b, c and
11b). Since COMMD4-FLAG partially corrected the defect in
cells depleted of COMMD4, we used siRNA #2 for the
remainder of our experiments.
COMMD4 is required for the repair of DNA DSBs. Following
induction of DSBs, hSSB1 rapidly localises to break-sites where it
recruits the MRN complex to allow ATM activation20–22. To
explore whether COMMD4 functions similarly, we depleted U2OS
cells of COMMD4 using siRNA and used immunofluorescence
to visualise the phosphorylation of histone H2AX (γH2AX), an
indirect marker of DSBs23,24, following ionising radiation (IR)
exposure. In COMMD4-depleted cells, γH2AX signals were
greatly enhanced, both prior to and post-DSB induction (Fig. 1c
and Supplementary Fig. 1d), with the defect partially rescued
by ectopic expression of COMMD4-FLAG (Supplementary
Fig. 1e–g). This was further confirmed by immunoblotting chro-
matin fractions of IR-treated cells (Supplementary Figs. 1h and
11c). To further explore how COMMD4-depletion contributes to
γH2AX foci formation, we performed structured illumination
microscopy (SIM), which resolved structures down to 120 nm.
This revealed that the enhanced γH2AX signal was due to an
increase in both the number and average foci size of γH2AX
(Fig. 1d, e). Importantly, the average signal per unit area of each
foci was unchanged, suggesting larger γH2AX represented
abnormal extension from the break-site. Consistent with these
findings, we also observed increased chromatin-bound hSSB1 and
MDC125 signals (Fig. 1f and Supplementary Fig. 2a), as well as
increased RPA26 and Rad5127 foci (Fig. 1g, h and Supplementary
Fig. 2b) in COMMD4-depleted cells, in-line with the presence of
more DSBs and larger repair foci.
Once a DSB is induced, the cell initiates signalling events to
activate cellular checkpoints and DSB repair1. HEK293T cells
depleted of COMMD4 demonstrated enhanced p53 S15 and
Chk2 T68 phosphorylation, consistent with increased activation
of the checkpoint (Supplementary Figs. 2c and 12).
To confirm that COMMD4-depleted cells have greater
numbers of DSBs, we used neutral COMET assays to directly
observe DNA fragmentation28. This showed that cells depleted of
COMMD4 had greater numbers of DSBs prior to and following
IR-exposure, compared to controls (Fig. 2a and Supplementary
Fig. 3a). We next analysed the activity of the two DSB repair
pathways, NHEJ and HR, using previously described in-cell
assays20,29–31. We initially measured NHEJ using a GFP-based
assay where the pEGFP-N1 vector was used as the reporter29,30
(Fig. 2b), subsequently measured HR in the MCF7 cell line, stably
integrated with a GFP-based HR reported26 (Fig. 2c) and both
NHEJ and HR together in U20S cell stably integrated with GFP
and mCherry-based reporters31 (Fig. 2d). These assays indicated
that both NHEJ and HR were functionally impaired in the
absence of COMMD4 (Fig. 2b–d), with a partial rescue by
COMMD4-FLAG (Fig. 2b, c) and a near complete rescue in stable
HEK293 cells expressing COMMD4-FLAG. This demonstrated
that COMMD4 function was required for a common processing
step required in both NHEJ and HR.
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Fig. 1 Loss of COMMD4 results in genomic instability. a, b U20S cells were transfected with COMMD4 esiRNA (#1) and/or siRNA #2, siRNA #3 and
siRNA #4 to deplete COMMD4 protein levels and treated with varying doses of IR or CPT. A clonogenic assay was subsequently carried out to
determine the sensitivity of COMMD4-depleted cells to these agents. AT5; cells from an A-T patient. Asterix (*) denotes p < 0.05. Error bars
represent mean ± SD from three independent experiments. c Immunofluorescence on control and COMMD4-depleted U2OS cells treated with 6 Gy of
IR followed by recovery at the time points shown and stained with γH2AX. d γH2AX foci in control and COMMD4-depleted cells using the OMX
super-resolution microscope. e Plot of γH2AX foci numbers for c and d. f Immunofluorescence experiment demonstrating MDC1 and hSSB1 foci
formation in control and COMMD4-depleted cells before and 2 h after irradiation. g, h Immunofluorescence experiment demonstrating RPA and Rad51
foci formation respectively in control and COMMD4-depleted cells before and after irradiation. DAPI shows the nucleus. ns not significant where p >
0.05, *p < 0.05 and **p < 0.005. Error bars represent mean ± SD from three independent experiments where 50 cells were quantified per condition.
Scale bar denotes 5 μm.
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Fig. 2 Repair of DNA double-strand breaks in COMMD4-depleted cells and interaction with hSSB1. a Comet assay showing the relative comet tail
moment in COMMD4-deficient and control cells at 0 and 0.5 h post treatment with 6 Gy IR. b Plot of the relative NHEJ events in control, cells treated with
DNA-PK inhibitor, COMMD4-depleted cells, COMMD4-depleted cells transiently overexpressing COMMD4-FLAG and cells stably expressing COMMD4-
FLAG, 48 h post-transfection with HindIII linearised EGFP-N3 plasmid. c Plot of I-Sce1 induced HR in control, hSSB1-depleted, COMMD4-deficient cells
and COMMD4-deficient cells overexpressing COMMD4-FLAG transiently and stably. d Plot of the relative NHEJ and HR events, respectively, in control,
DNA-PK inhibitor, hSSB1 siRNA and COMMD4-depleted cells using a quantitative reporter assay that measures NHEJ versus HR in the same cells
through the repair of two inverted I-Sce1 cuts. e A direct interaction between COMMD4 and WT hSSB1, T117E and S134E hSSB1. COMMD4 was used to
pull-out the protein complexes. IgG is the negative control and COMMD4 shows the loading. f ChIP-qPCR assay with primers at 94–378 and 300–643 bp
from the break-site in DRGFP cells transfected with COMMD4-FLAG, ± I-Sce1. The enrichment of COMMD4 after induction of a DSB was compared to
the IgG control and - I-Sce1 sample. Significant recruitment was only observed at 300–643 bp. The schematic of the assay and the primer pairs used
is shown below. *p < 0.05, **p < 0.005, ns non-significant where p > 0.05. Error bars represent mean ± SD from three independent experiments.
g Immunofluorescence showing localisation of FLAG-COMMD4 and RNF20 at a DSB induced by the I-SceI restriction enzyme in MCF7 DRGFP cells.
Scale bar denotes 5 μm.
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Subcellular localisation of COMMD4 and its recruitment to
the sites of damage. To determine whether COMMD4 functions
directly in the repair process, we next examined if COMMD4
localises to break-sites. We detected endogenous COMMD4
in the nucleus by immunoblotting of subcellular fractions
(Supplementary Figs. 3b and 13). Immunofluorescence in U2OS
cells ectopically expressing COMMD4-FLAG revealed nuclear
and cytoplasmic staining (Supplementary Fig. 3c), supporting our
subcellular fractionations. Interestingly, γH2AX did not directly
co-localise with COMMD4-FLAG; it was however found imme-
diately adjacent to over 50% of γH2AX foci. This was further
corroborated by immunofluorescence of endogenous COMMD4
in U2OS cells (Supplementary Fig. 3d, f). COMMD4 foci were
also adjacent to, but not overlapping with 53BP1 foci32 (Sup-
plementary Fig. 3e, f). The adjacent localisation between
COMMD4 and 53BP1 foci further demonstrates that COMMD4
may be required for correct remodelling of chromatin which
precedes both γH2AX and 53BP1 foci formation.
We next investigated how COMMD4 is recruited to break-
sites and if its recruitment is mediated by hSSB1. Co-
immunoprecipitation assays revealed that COMMD4 and hSSB1
form a complex in cells (Supplementary Figs. 4a and 14a) and
in vitro pull-down assays using purified COMMD4 and
hSSB1 showed a direct interaction (Fig. 2e and Supplementary
Fig. 8). We included T117E and S134E phosphomimetic
mutants of hSSB1, which represent the damage-induced
phosphorylation of hSSB1 by ATM20 and DNA-PK33, respec-
tively. These data suggest that while hSSB1 and COMMD4
interact regardless of hSSB1 phosphorylation, their interaction is
enhanced by phosphorylation of hSSB1 at T117/S134. We next
used siRNA to deplete hSSB1 from cells and assessed COMMD4
foci formation by immunofluorescence (Supplementary Fig. 4b).
The reduced formation of IR-induced COMMD4 foci in the
absence of hSSB1 indeed support a requirement for hSSB1 in the
recruitment of COMMD4 to sites of DSBs, likely involving a
direct interaction between COMMD4 and phosphorylated
hSSB1. Furthermore, the ATM inhibitor KU-55933 demon-
strated reduced formation of IR-induced COMMD4 foci
(Supplementary Fig. 4c).
We next determined whether COMMD4 localised to a site-
specific DBS using a chromatin immunoprecipitation (ChIP)
assay with DRGFP cells previously described (Fig. 2c) and
overexpressed COMMD4-FLAG transiently. I-Sce1 was used to
introduce a site-specific DSB and FLAG antibody was employed
to immunoprecipitate COMMD4. The enrichment of COMMD4
after the induction of a DSB was compared to the IgG control and
the - I-Sce1 sample, using two primer pairs; one immediately
adjacent to the break-site and the other at 300 bp or greater away
from the break-site20,34 (Fig. 2f). The ChIP assay demonstrated
that COMMD4 specially localised to a site within 300–643 bp
away from the I-Sce1-induced DSB. This data further demon-
strate that COMMD4 precipitates and is enriched in the DNA
that is at least 300 bp away from the break-site. hSSB1 was
previously seen at 94–378 bp from the I-Sce1 break-site20. We
also observed the co-localisation of COMMD4 and RNF20 at a
site-specific DSB by the I-SceI restriction enzyme in the DRGFP
cells (Fig. 2g).
COMMD4 associates with the histone, H2B and the E3 ubi-
quitin ligase complex, RNF20/40. Following DSB induction, the
chromatin surrounding the break-site must be remodelled. Part of
this remodelling involves the monoubiquitination of H2B by the
ubiquitin ligase RNF20/40 complex in an ATM-dependent
manner; a process required for the efficient repair of DSB by
HR and NHEJ35–37. This monoubiquitination of H2B has been
shown to disrupt chromatin compaction and inter-fibre interac-
tions, leading to an open and accessible chromatin fibre38.
To determine if COMMD4 is involved in chromatin remodel-
ling at break-sites, we investigated whether COMMD4 associated
with the histone H2B and the E3 ubiquitin ligase complex
RNF20/40. We immunoprecipitated FLAG-tagged COMMD4
from HEK293 cells stably expressing COMMD4-FLAG, with M2
magnetic agarose beads and immunoblotted for H2B, RNF40 and
COMMD4 (Fig. 3a and Supplementary Fig. 9a). These experi-
ments demonstrated that COMMD4 associated with both H2B
and RNF40. However, following irradiation, while the interaction
between COMMD4 and RNF40 did not change, COMMD4 and
H2B dissociated (Fig. 3b and Supplementary Fig. 9b). An in vitro
binding assay, using purified proteins, additionally demonstrated
that COMMD4 interacted directly with RNF20 and RNF40
(Supplementary Figs. 4d–f and 14b, c).
Characterising the interaction between COMMD4, H2B and
RNF20/40. Following the induction of a DSB, H2B is phos-
phorylated at Ser14 and occurs downstream of ATM signalling39.
The dissociation of COMMD4 from phosphorylated H2B sug-
gests that COMMD4 may protect H2B from monoubiquitination
by RNF20/40. To investigate whether COMMD4 binds directly to
H2B and if ATM regulates this binding, we incubated purified
COMMD4-FLAG with recombinant H2B and utilised M2 mag-
netic agarose to pull-down COMMD4 bound to H2B. As H2B has
been previously shown to be phosphorylated following DSB
formation39, we performed this assay in the presence of recom-
binant ATM. These data showed that COMMD4 bound directly
to unmodified H2B and that this interaction was disrupted by the
presence of active ATM (Fig. 3c and Supplementary Figs. 4g and
9c). The addition of the ATM kinase inhibitor, KU-55933,
restored the interaction between COMMD4 and H2B (Fig. 3d and
Supplementary Figs. 4h and 9d), highlighting that it is the
phosphorylation of H2B at Ser14 that disrupts their interaction.
We next purified an S14E phosphomimetic mutant of H2B and
repeated the pull-down assay with COMMD4 (Fig. 3e and Sup-
plementary Fig. 9e). As expected, we were unable to detect an
association between COMMD4 and S14E H2B.
We next used a peptide-mapping strategy to determine the
exact site of interaction between COMMD4 and H2B. H2B was
reduced to a series of 20 amino acid partially overlapping peptides
containing a C-terminal Biotin tag (Supplementary Table 1) and
we performed pull-down assays between COMMD4 and each
peptide (Fig. 3f and Supplementary Fig. 9f). These assays
demonstrated that COMMD4 bound specifically to the sequences
2, 4, 8 and 10 on H2B, as no binding was seen in the negative
control with only the beads plus recombinant COMMD4.
We next used peptide-mapping to determine the site of
interaction between RNF20/40 and H2B. RNF40 (Fig. 3g and
Supplementary Fig. 9g) specifically bound to the sequences 2, 5, 7,
8, 11 and 12 of H2B, while RNF20 (Supplementary Figs. 4i and
14d) bound to the sequences 2, 5, 7 and 8. This demonstrated that
RNF20/40 bound preferentially to KDGKKRKRSRKESYSI of H2B
(Fig. 3h), as the H2A-H2B dimer structure (NMR) (PDB code:
2RVQ) provided us with two potential COMMD4 binding
regions, amino acids 25–44 and 61–80. As RNF20/40 bound
weakly to peptides 1 and 7 of H2B (which includes the Ser14
phosphorylation site), we next sought to determine whether the
phosphorylation of H2B on Ser14 would increase RNF40 binding
to the H2B peptides 1/7 (Supplementary Figs. 4j and 14e). In the
presence of ATM, we observed increased binding between RNF40
and H2B peptide 7, indicating that phosphorylation of H2B
at Ser14, while displacing COMMD4, recruits RNF20/40. To
confirm this was due to the S14 phosphorylation of H2B, we
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incubated recombinant RNF40 with recombinant H2B or the S14E
phosphomimic mutant and saw increased binding of RNF40 to the
S14E mutant, confirming the importance of this phosphorylation
event (Supplementary Figs. 4k and 14f). We additionally used
FLAG-tagged COMMD4 mutants (Supplementary Table 2) to
further confirm the importance of the N-terminal domain of
COMMD4 for its function. These mutants of COMMD4 showed
reduced binding with H2B (Supplementary Figs. 4l and 14g) and
reduced NHEJ and HR repair compared to the overexpression of
wild-type COMMD4 (Supplementary Fig. 4m).
COMMD4 regulates the monoubiquitination of H2B. In
undamaged cells, the RNF20/40 complex is involved in H2B
monoubiquitination during transcription elongation40, making it
difficult to observe DSB-induced monoubiquitination of H2B. To
overcome this, we treated cells with the transcription inhibitor,
Actinomycin D, prior to IR which removes the transcription-
associated monoubiquitinated H2B signal, allowing the DSB
signal to be observed36. In the presence of Actinomycin D,
COMMD4-depleted U2OS cells showed an increase in H2B
monoubiquitination compared to control siRNA-depleted cells
(Fig. 4a and Supplementary Fig. 10a). The monoubiquitination
levels after the addition of Actinomycin D was much reduced,
compared to cells not treated with Actinomycin D, as previously
shown36. However, COMMD4-depleted cells treated with both
Actinomycin D and IR showed a marked increase in H2B
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Fig. 3 COMMD4 interacts with H2B and RNF40. a Empty vector (FLAG) and COMMD4-FLAG were immunoprecipitated from HeLa cells and the co-
eluting proteins were immunoblotted with antibodies shown. b Immunoprecipitation as a, but this time cells were treated with 6 Gy IR. c A direct
interaction for COMMD4 and H2B ± recombinant ATM. d A direct interaction between COMMD4 and H2B ± recombinant ATM and the ATM inhibitor
(ATMi) KU-55933. e FLAG and FLAG-tagged H2B WT, and S14E mutant were immunoprecipitated from HeLa cells and the co-eluting proteins were
immunoblotted with antibodies against COMMD4 and H2B. IgG heavy chain shows the loading. f Direct interaction between COMMD4 and H2B
demonstrating the specific binding region within H2B. No binding was seen in the negative control with only the beads and recombinant COMMD4
(beads), while expression of His-tagged COMMD4 (COMMD4, right most lane) is seen. Schematic on the right shows peptide regions within H2B and
Supplementary Table 1 shows the peptide sequences. g Direct interaction between RNF40 and H2B demonstrating the specific binding regions within H2B.
Expression of recombinant RNF40 is seen in the control lane. h A three dimensional structure (PDB code 2RVQ) of the heterodimer H2A-H2B wherein
H2A and H2B are shown in blue and red ribbon representation, respectively. Tails of histones are disordered and in extended conformation. The
phosphorylation sites are shown as spheres.
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monoubiquitination, relative to the control siRNA cells treated
with both Actinomycin D and IR, suggesting that in the absence
of COMMD4, H2B is over-monoubiquitinated at DSB sites, a
process that could prevent correct repair of the break (Fig. 4a and
Supplementary Fig. 5a–c). Supporting this, immunofluorescence
of COMMD4-depleted cells demonstrated a pronounced increase
in the levels of RNF40 located at DSB sites, compared to controls,
suggesting deregulation of remodelling at the break-site in
COMMD4’s absence (Fig. 4b and Supplementary Fig. 5d).
These data highlight an important role for COMMD4 in the
repair of DSBs in both HR and NHEJ, where COMMD4
functions to limit the activity of remodelling proteins at the
DSB site. If COMMD4 were regulating RNF20/40 activity at sites,
then, transient overexpression of COMMD4 could inhibit the
monoubiquitination of H2B by RNF20/40 and thus inhibit both
NHEJ and HR. This was indeed the case, with the ectopic
expression of COMMD4-FLAG impairing both NHEJ and HR
activity, presumably by preventing chromatin remodelling at DSB
sites and thus explaining why complete rescue of NHEJ and HR
activity in COMMD4-depleted cells was not possible (Supple-
mentary Fig. 6). However, an siRNA-resistant stable cell line
(HEK293-COMMD4-FLAG) that expressed near endogenous
IR 2h 10Gy       -             -             -             -                 +             +                 
Act D (2h)      -              -            +             +                +             +           





















































0h COMMD4 si 
#3
0h COMMD4 si 
#4
4h COMMD4 si 
#2
4h COMMD4 si 
#3
4h COMMD4 si 
#4
Recombinant COMMD4 + Recombinant H2A or H2B






















Recombinant H2A + CK2 + Recombinant H2B 
+ Recombinant COMMD4 (COMMD4 pull-down)



















































Recombinant H2A + CK2 + Recombinant H2B 
+ Recombinant COMMD4 (H2B pull-down)
- COMMD4
- H2B
H2A + H2B 
+ COMMD4 
Input











































Fig. 4 COMMD4 binds to histone H2A-H2B and regulates the monoubiquitination of H2B. a Immunoblot showing H2B monoubiquitination in control and
COMMD4-depleted cells ±5 μg/ml of Actinomycin D and ±irradiation. b Immunofluorescence showing RNF40 protein levels with 6 Gy IR at 0 and 4 h
post-IR treatment in control and COMMD4-depleted cells. Scale bar denotes 5 μm. Fifty cells were quantified per condition. c In vitro ubiquitination assay
of H2B ± recombinant COMMD4 or with COMMD4 and without the E2 enzyme. Monoubiquitination and polyubiquitination of H2B is shown. d Direct
interaction between COMMD4 and H2A/H2B, demonstrating that COMMD4 preferentially binds H2B. e In vitro direct interaction between H2A, H2B and
COMMD4 ± recombinant CK2. H2B was used pull-out the complexes and shows loading. f Same as e, however, COMMD4 was used to pull-out the
complexes. g Direct interaction between H2A, H2B and COMMD4, in the absence and presence of purified nucleosomes, ±recombinant ATM and CK2.
COMMD4 was used pull-out the complexes and shows the loading.
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levels of COMMD4 was able to completely rescue COMMD4-
depletion (Fig. 2b, c).
To further explore if COMMD4 was able to interact with the
N-terminus of H2B and at the same time, limit the ubiquitination
of H2B at the C-terminus, we performed an in vitro ubiquitina-
tion assay in the absence and presence of purified COMMD4-
FLAG. COMMD-FLAG was incubated with recombinant H2B
and purified recombinant components of the RNF20/40 ubiqui-
tination complex (E1, E2, RNF20/40 (E3) and ubiquitin). We
observed reduced H2B monoubiquitination in the reactions
containing recombinant COMMD4, compared with the reaction
without (Fig. 4c and Supplementary Fig. 10b), demonstrating that
COMMD4 was capable of limiting the ubiquitination of H2B by
RNF20/40 at its C-terminus in a purified protein system.
COMMD4 binds to the histone H2A-H2B dimer. The phos-
phorylation of H2A by the CK2 kinase at tyrosine 57 is required
for the regulation of transcription elongation41 and additionally
affects H2B monoubiquitination and trimethylation of lysine in
H341,42. Phosphorylation of H2A by CK2 on this helix results in a
loss of binding affinity between H2A and H2B due to steric
hindrance by the phosphorylation site43. To confirm whether
COMMD4 bound only to H2B or to both H2A and H2B, we
performed an in vitro binding assay between COMMD4 and H2A
or H2B, which demonstrated that COMMD4 bound to both
H2A and H2B, but preferentially bound to H2B (Fig. 4d and
Supplementary Fig. 10c). To next elucidate whether COMMD4
preferentially bound to H2B as a heterodimer with H2A, we
carried an in vitro binding assay with recombinant H2A, H2B
and COMMD4, in the absence and presence of the CK2 kinase. In
the presence of CK2, we saw reduced binding between COMMD4
and H2B, demonstrating that while COMMD4 binds to H2B in
the absence of H2A, it has a preference for the H2B-H2A het-
erodimer (Fig. 4e, f and Supplementary Fig. 10d, e). Additionally,
in the presence of CK2, we saw COMMD4 now preferentially
binding to H2A (Fig. 4f and Supplementary Fig. 10e). To deter-
mine whether the interaction between COMMD4 and H2A-H2B
are maintained in nucleosomes, we performed in vitro binding
assays between COMMD4 and either the H2A-H2B dimer, non-
remodelled human native nucleosomes or nucleosomes that have
been remodelled after phosphorylation by the ATM and CK2
kinases (Fig. 4g and Supplementary Fig. 10f). Our data with
nucleosomes confirmed our experiments with purified recombi-
nant H2A/H2B, demonstrating that COMMD4 does not bind to
non-remodelled nucleosomes and requires the action of both
ATM and CK2 kinases, after the induction of DNA damage, to
gain access to the internalised H2A-H2B binding site.
Previous data44,45 have shown that following chromatin
remodelling, transient conformations of histones may dissociate
the H2A-H2B dimer from the nucleosome, thus corroborating the
binding of COMMD4 to H2A-H2B, even though the histone
binding site may be internally buried within the nucleosome. Our
data support a role for COMMD4 in preventing RNF20/40 access
to H2B until nucleosome remodelling has been initiated. This
remodelling and post-translational modifications results in RNF20/
40 gaining access to H2B allowing further nucleosome remodelling
to occur. Interestingly, after H2A and H2B phosphorylation,
COMMD4 does not leave the remodelling site, instead binding to
H2A (Supplementary Fig. 7).
Discussion
The DNA repair pathways have evolved in human cells as a means
to maintain the genetic stability of a cell, preventing mutations that
can result in diseases such as cancer1,2. Here we report a previously
undescribed role for COMMD4 in maintaining genomic stability
through the regulation of chromatin structure at sites of DSBs. We
found that cells depleted of COMMD4 were sensitive to several
DNA damaging agents that cause DSBs and are defective in their
repair of DSBs. To explore this further, we utilised several assays to
measure the repair of DSBs by NHEJ and HR in control and
COMMD4-depleted cells, which indicated that both NHEJ and HR
are functionally impaired in the absence of COMMD4. Further-
more, a COMMD4 ChIP assay demonstrated that COMMD4
localised adjacent to a DSB site, but not immediately proximal to
the site.
The remodelling of chromatin at DSBs is a common feature of
HR and NHEJ repair and allows signalling and repair proteins to
access these sites8. Co-immunoprecipitation of COMMD4 and
in vitro direct binding assays revealed an interaction with the
histones H2A/H2B and the chromatin modifier RNF20/40,
suggesting COMMD4 may also be involved in regulating
chromatin structure at DSB sites. Interestingly, while we found
that COMMD4 interacts directly with H2B, our data demon-
strate that this interaction is disrupted by the phosphorylation
of H2B at Ser14 in the presence of recombinant ATM. ATM-
mediated phosphorylation of RNF20/40 has previously been
shown to be required for regulating the monoubiquitination of
H2B, which leads to H2B dissociation from the chromatin and
‘opening’ of the break-site for repair35,36,38,40,46. We and
others35,36 have observed increased H2B monoubiquitination
following IR-induced DSB formation. This is contrary to a
recent publication47, where loss of H2B monoubiquination was
observed after DSBs induced by AsiSI.
Our data suggest that COMMD4 protects H2B from RNF20/40
until its phosphorylation at serine 14. Once COMMD4 is dis-
placed, RNF20/40 can then bind to H2B and ubiquitinate lysine
120, which in turn stimulates the release of H2B from the
chromatin.
We used in vitro pull-down assays to map the interaction
between H2B and COMMD4, which showed that COMMD4
bound to both H2B and the H2A-H2B dimer. However, following
the induction of DNA damage, as H2B is phosphorylated,
COMMD4 is displaced from H2B, allowing RNF20/40 access to
monoubiquitinate H2B. Indeed, our data support that phos-
phorylation of H2B and H2A is the molecular switch that causes a
decrease in COMMD4’s affinity for H2B, allowing COMMD4 to
preferentially bind to H2A and consequently enable RNF20/40 to
shift over to the Ser14 site of H2B.
Our data were further corroborated with experiments with
native nucleosomes. Here we demonstrated that COMMD4
cannot bind to unperturbed chromatin as the binding site is not
available. Upon the induction of DNA damage, the ATM and
CK2 kinases remodel the nucleosome, enabling the binding of
COMMD4.
Taken together, our findings demonstrate that COMMD4 is a
critical component of the genome stability pathway, functioning
to limit the extent of epigenetic modification of the chromatin
around the break-site. Loss of COMMD4 results in a loss of
RNF20/40 regulation and uncontrolled remodelling. The regula-
tion of COMMD4 and RNF20/40 activity is controlled so that
remodelling can be finely tuned. Since RNF20/40 are in a con-
stitutive complex with COMMD4, this provides a mechanism
whereby activation and suppression of H2B ubiquitination can be
finely and rapidly controlled. While further structural insight via
cryo-EM or crystallography will be needed to finely map the
details of the molecular mechanism, it is likely that binding of
COMMD4 to H2A places RNF20/40 proximal to H2B allowing it
to effectively ubiquitinate H2B.
COMMD4 levels within the cell must be tightly controlled as
both depletion and overexpression of COMMD4 can result in
defects in both the NHEJ and HR. We anticipate our data will
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shed further light on how cells repair DSBs and in particular, how
cells control repair of these breaks. We speculate that COMMD4
may become a therapeutic target for the treatment of cancer.
Methods
Cell lines and cell treatments. U20S, HeLa, HEK293 and HEK293T cells (ATCC)
were cultured in Roswell Park Memorial Institute 1640 medium (Life Technolo-
gies). A-T patient cells (AT5)29 were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) (Life Technologies). MCF7 cells stably expressing a green
fluorescent protein reporter gene (pDRGFP) were cultured in DMEM media
containing 10 μg/ml insulin (Life Technologies) and U20S cells stably expressing
the DNA repair reporter were cultured in DMEM media. All media contained 10%
fetal bovine serum, and all cells were maintained in a humidified incubator at
37 °C/5% CO2. Camptothecin and Actinomycin D were purchased from Sigma-
Aldrich. The ATM inhibitor (KU-55933) and DNA-PK inhibitor (KU-57788) were
purchased from Selleckchem. Irradiations were carried out using a 137Cs source
(Gammacell 40 Exactor [MDS Nordion]; dose rate 1.1 Gy/min).
Antibodies. Primary antibodies: anti-COMMD4 (Abcam, ab115169 and Bioss, bs-
8037R), anti-Histone H3 (Sigma-Aldrich, H0164), anti-nucleolin (Cell Signalling,
12247S), anti-γH2AX (Abcam, ab26350), anti-FLAG (Sigma, F1804), anti-MDC1
(Sigma, PLA0016), anti-p53 Serine 15 (Cell Signalling, 9284), anti-p53 clone D0-7
(Sigma-Aldrich, p8999), anti-Chk2 Threonine 68 (Cell Signalling, 2661), anti-Chk2
(Cell Signalling, 2662), anti-ATM Serine 1981 (Cell Signalling, 13050), anti-ATM
(Cell Signalling, 2873), anti-β-actin (BD Biosciences, 612656), anti-H2B (Abcam,
ab1790), anti-ubiquityl-histone H2B (Lys120) (Cell Signalling, 5546), anti-RNF20
(Abcam, ab32629 and Merck, MABE948), anti-RNF40 (Abcam, ab126959), anti-
H2A (Abcam, 88770), anti-53BP1 (Merck-Millipore, MAB3802), anti-ubiquitin
(Cell Signalling, 3936) and anti-hSSB120–22. For co-immunoprecipitations and
in vitro assays, the following IgG controls were used; normal rabbit IgG (Cell
Signalling, 2729), normal mouse IgG (Sigma-Aldrich, N103) and normal sheep IgG
(Sigma-Aldrich, 12-515).
Secondary antibodies for immunoblotting: IRDye® 680CW Donkey anti-rabbit,
IRDye® 800CW Donkey anti-mouse and IRDye® 800CW Donkey anti-goat from
LI-COR, Inc.
Secondary antibodies for immunofluorescence: Alexa Fluor® 488 donkey anti-
mouse (A21202), Alexa Fluor® 488 donkey anti-rabbit (A21206), Alexa Fluor® 594
donkey anti-mouse (A21203) and Alexa Fluor® 594 donkey anti-rabbit (A21207)
from (Life Technologies).
Expression constructs, siRNA and transfections. U20S, HeLa or HEK293T cells
were transfected with either control esiRNA (MISSION® siRNA targeting EGFP,
Sigma-Aldrich) or COMMD4 esiRNA (Sigma-Aldrich) or alternatively control
siRNA (MISSION® siRNA Universal Negative Control #1, Sigma-Aldrich) or
COMMD4 siRNA #2 (CCAUGUCCCUCUCAGCAGA[dT][dT] MISSION®
siRNA, Sigma-Aldrich), COMMD4 siRNA #3 (GUCUGCAGCCUACGCAUGA
[dT][[dT] MISSION® siRNA, Sigma-Aldrich) or COMMD4 siRNA #4 (GGU-
GUUCCAGGCCUGUGUG[dT][dT] MISSION® siRNA, Sigma-Aldrich) and
hSSB1 and ATM siRNA20, using RNAiMax (Life Technologies) as recommended
by the manufacturer and samples were analysed 48–72 h post-transfection. HeLa,
U2OS, HEK293 or HEK293T cells were transfected with a COMMD4 siRNA-
resistant plasmid18 using FuGENE® HD (Promega) as per manufacturer’s
instructions and samples were analysed 24 h post-transfection. H2B and H2B S14E
mutant with a C-terminal FLAG tag were cloned into the mammalian expression
vector pCDNA3.1/Zeo (−) and were purchased from GenScript. The plasmids
were transfected into HeLa or HEK293T cells using FuGENE® HD and samples
were analysed 24 h post-transfection. COMMD4 with an N-terminal His tag,
cloned into the expression vector pET-28a(+), was purchased from GenScript.
Subcellular fractionation and immunoblotting. Cells were separated into sub-
cellular fractions using the subcellular protein fractionation kit for cultured cells
(Thermo Scientific), according to the manufacturer’s instructions. Total cell lysates
were prepared using ice-cold NP40 buffer (20 mM HEPES pH 8, 150 mM KCl,
10 mM MgCl2, 0.5 mM EDTA, 0.2% NP40, 0.5 mM DTT, 5% glycerol, 1X protease
inhibitor cocktail, 1X phosphatase inhibitor cocktail and 1X Pierce Universal
Nuclease for cell lysis (Thermo Fisher)) and lysed by sonication48,49. Protein
concentrations were estimated using a Bicinchoninic acid kit for protein deter-
mination (Sigma-Aldrich) and subsequently 5 μg of the fractions and/or 15 μg of
total cell lysate were separated on 4–12% Bis-Tris Plus Bolt precast gels (Life
Technologies), immunoblotted with the antibodies shown and imaged with an
Odyssey infra-red imaging system (LI-COR).
Immunofluorescence microscopy. U20S and HeLa cells transfected with control
or COMMD4 siRNA were grown in optical glass bottom 96 well plates (Cellvis) or
μ-slide 8 well glass bottom chamber slides (ibidi). Following IR treatment, cells were
pre-extracted for 5 min with ice-cold extraction buffer (20mM HEPES (pH 8),
20mM NaCl, 5 mMMgCl2, 1 mM ATP, 0.5% NP40), to remove the soluble proteins
and processed as previously described22. Images were taken using a Delta Vision
PDV microscope, ×600/1.42 or ×100/1.42 Oil objective (Applied Precision, Inc) or
the OMX Blaze deconvolution SIM super-resolution microscope, ×60/1.42 two Oil
objective (Applied Precision, Inc). All immunofluorescence figures were assembled
using Adobe Photoshop CS6. High content imaging was performed using the IN
Cell Analyzer 2200 Imaging System (GE Healthcare Life Sciences). Images were
analysed using the IN Cell Investigator software (GE Healthcare Life Sciences) with
a minimum of 50 nuclei quantified per independent experiment.
Colony forming assays. For colony forming assays, following siRNA-depletion,
500 cells for each condition were plated in well of a 6-well plate, treated with the
DNA damaging agent the following day and allowed to recover for 8–10 days20,50.
Each condition was plated in triplicate and repeated three independent times. Data
are represented as means and SD.
Neutral comet assay. The neutral comet assay was carried out using U2OS cells
that were treated or mock treated with 6 Gy of IR. Briefly, ± treatment, cells were
embedded in agarose followed and electrophoresed. Cells were lysed as previous
(10 mM Tris, pH 10, 2.5 M NaCl, 100 mM EDTA and 1% Triton X100) and
singular cells were stained with Sybr Green (Thermo Fisher Scientific), with 50 cells
chosen per condition for analysis and ImageJ was used to analyse the relative olive
tail moment48.
Homologous recombination assays. HR was assessed by determining the fre-
quency of reconstitution of the green fluorescent protein reporter gene (pDRGFP)
stably expressed in MCF7 cells51. MCF7 DRGFP cells were initially depleted of
hSSB1 or COMMD4 and 48 h later I-Sce1 was transiently expressed from the
pCBSCE expression vector. Flow cytometry (Gallios Flow Cytometer, Beckman
Coulter Life Sciences) was subsequently performed to determine the percentage of
GFP positive cells and analysed using the Kaluza software (Beckman, Lane Cove
NSW, Australia).
Non-homologous end-joining assay. The pEGFP-N3 vector (Clontech) was
digested with HindIII (New England BioLabs) for 6 h to cleave between to GFP
coding region and promoter. The plasmid was subsequently separated by agarose
gel electrophoresis and then gel purified using a gel clean-up kit (Promega).
HEK293T cells transfected with either control or COMMD4 siRNA were subse-
quently transfected with either the uncut pEGFP-N3 or HindIII linearised plasmid,
using FuGENE® HD (Promega) and incubated for 48 h prior to harvest. Flow
cytometry was performed to determine the percentage of GFP positive cells29.
Analysis of NHEJ and HR function using an in vivo fluorescence-based
reporter. U20S cells stably expressing the DNA repair reporter were transfected
with control and COMMD4 siRNA, as previously described. In total, 48 h post-
transfection, the cells were transfected with both the I-Sce1 and exogenous donor
plasmids. In total, 48 h post-transfection of the plasmids, cells were trypsinised and
flow cytometry was performed to determine the percentage of GFP positive and
mCherry positive cells31.
Co-immunoprecipitations. Assays for co-immunoprecipitations were performed
at 4 °C from HEK293T, HEK293 or HeLa cells transiently expressing the full-
length COMMD4-FLAG plasmid and cells were lysed with ice-cold NP40 buffer.
The plasmid pCMV6-AC-3DDK (FLAG) was used as the negative control and
proteins were captured using anti-FLAG M2 Dynabeads (Sigma-Aldrich) and
washed three times in NP40 buffer prior to analysis.
Direct interaction between COMMD4 and hSSB1. In total, 300 ng of recombi-
nant COMMD4, purified from the pET-28a expression vector, was incubated with
either 500 ng of WT hSSB121, T117E20 or S134E33 for 1 h at 4 °C in NP40 buffer.
COMMD4 antibody bound to Protein A Dynabeads (Thermo Fisher Scientific) was
used to pull-out the complex. The beads were washed three times with NP40
buffer, resuspended in 4X Laemmli sample buffer (250 mM Tris pH 6.8, 8% SDS,
4% glycerol, 0.02% bromophenol blue, 8% β-mercaptoethanol) and immunoblotted
with anti-COMMD4 and anti-hSSB1 antibodies.
Chromatin immunoprecipitation. ChIP assays were performed using the Sim-
pleChIP® Plus Sonication Chromatin IP Kit (Cell Signalling) in DRGFP cells51,
according the manufacturer’s procedure and additionally using the protocol pre-
viously described52. Briefly, COMMD4-FLAG was overexpressed in DRGFP cells
and 16 h later, cells were transfected with I-Sce1. In total, 12–24 h post-transfection
with I-Sce1, ~2–5 × 107 DR-GFP cells with and without I-Sce1 induction were fixed
with formaldehyde to cross-link the DNA and proteins and chromatin was sheared
by sonication. FLAG antibody was used to immunoprecipitate COMMD4, the
protein-DNA cross-links were reversed and DNA was purified and analysed by
qPCR using the primers previously described20,34.
Direct interaction between COMMD4 and H2B. FLAG-tagged COMMD4 was
purified from stable HEK293 cells expressing COMMD4-FLAG, while we
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purchased recombinant H2B (NEB) and ATM (Merck). Lysates were incubated for
1 h at 4 °C either with protein G Dynabeads (Thermo Fisher Scientific) bound with
FLAG antibody or normal mouse IgG. Following the incubation, the beads were
washed with high salt buffer (20 mM HEPES pH 8, 500 mM KCl, 10 mM MgCl2,
0.5 mM EDTA, 0.2% NP40, 5% glycerol) followed by a wash with 250 mM Lithium
chloride to remove the non-specific interactors. In total, 700 ng of H2B was pre-
incubated with 35 ng of recombinant active ATM for 30 min at 37 °C in ATM
kinase buffer (10 mM Hepes pH 7.5, 50 mM β-glycerophosphate, 50 mM NaCl,
10 mM MgCl2, 10 mM MnCl2, 1 mM DTT, 500 μM ATP) with and without the
ATM inhibitor, KU-55933 (Selleckchem). Following the pre-incubation, H2B was
added to COMMD4-FLAG for 10 min in the absence or presence of ATM. The
beads were subsequently washed several times with high and medium salt buffer
(20 mM HEPES pH 8, 250 mM KCl, 10 mM MgCl2, 0.5 mM EDTA, 0.2% NP40,
5% glycerol), and resuspended in 4X Laemmli sample buffer and immunoblotted
with anti-H2B and anti-FLAG antibodies.
Structure of histone H2A-H2B. The structure of the histone H2A-H2B dimer
(PDB: 2RVQ)53 was downloaded from the protein data bank.
Mapping the interaction site of H2B and COMMD4. A peptide-mapping
strategy was used to determine the exact site of interaction between H2B and
COMMD4. H2B was reduced to a series of 20 partially overlapping peptides
containing a C-terminal Biotin tag (Supplementary Table 1) and was purchased
from GenScript. In total, 300 ng of recombinant COMMD4, purified from the pET-
28a expression vector, was incubated with 1.2 μg of each peptide in NP40 buffer for
1 h at 4 °C. Proteins were captured using Streptavidin Dynabeads (Sigma-Aldrich),
washed three times in NP40 buffer, resuspended in 4X Leammli sample buffer and
immunoblotted with the anti-COMMD4 antibody.
Mapping the interaction site of RNF20/40 and H2B. In total, 700 ng of
recombinant active human RNF20 or RNF40 (University of Dundee) was incu-
bated with 1.2 μg of each peptide in NP40 buffer for 1 h at 4 °C. Proteins were
captured using Streptavidin Dynabeads (Sigma-Aldrich), washed three times in
NP40 buffer, resuspended in 4X Leammli sample buffer and immunoblotted with
the anti-RNF20 or RNF40 antibodies.
In vitro ubiquitination assay. FLAG-tagged COMMD4 was purified from stable
HEK293 cells expressing COMMD4-FLAG, while we purchased recombinant H2B
(Cell Signalling), human E1 Ubiquitin Activating Enzyme Protein (Abcam), human
Ube2B E2 protein (Abcam), human active RNF20 and RNF40 and human Ubi-
quitin protein (Abcam). FLAG-tagged COMMD4 was purified as described earlier.
In total, 50 ng of E1, 300 ng of E2 and 5 μg of ubiquitin was added to 3.5 μl of 10X
Ubiquitination buffer (50 mM Tris pH 8, 5 mM MgCl2, 0.1% Tween 20, 1 mM
DTT). To the reaction, 500 μM ATP, FLAG-tagged COMMD4 on Protein G
Dynabeads and 100 ng of H2B was added, the reaction was made up to 48 μl with
water and 200 ng of RNF20/40 was added to make up the final reaction volume to
50 μl. The reaction was then incubated for 30 min at 4 °C and following the
incubation, resuspended in 4X Laemmli sample buffer and immunoblotted with
the antibodies indicated.
Direct interaction between COMMD4 and H2A or H2B. In total, 300 ng of
recombinant COMMD4, purified from the pET-28a expression vector, was incu-
bated with either 300 ng of H2A (NEB) or H2B (NEB) for 1 h at 4 °C in NP40
buffer. H2A or H2B bound to Protein A Dynabeads (Thermo Fisher Scientific) was
used to pull-out the complex. The beads were subsequently washed several times
with high salt buffer, resuspended in 4X Laemmli sample buffer and immuno-
blotted with anti-COMMD4 and anti-H2A/H2B antibodies.
In vitro binding of H2A, H2B and COMMD4. In total, 300 ng of H2A was pre-
incubated with 2 μl of recombinant active CK2 (500,000 units/ml, NEB) for 1 h at
30 °C in kinase buffer. Following the pre-incubation, 300 ng of H2B was added at
4 °C for 30 min, followed by the addition of 300 ng of recombinant COMMD4 for
30 min at 4 °C. H2B or COMMD4 bound to protein A Dynabeads (Thermo Fisher
Scientific) were used to pull-out the bound complexes. The beads were subse-
quently washed several times with high and medium salt buffer, resuspended in 4X
Laemmli sample buffer and immunoblotted with the antibodies indicated.
In vitro binding of COMMD4 and nucleosomes. In total, 780 ng of human native
nucleosomes (Merck) were pre-incubated with and without 2 μl of recombinant
active CK2 (500,000 units/ml, NEB) and 35 ng of recombinant active ATM, for 1 h
at 30 °C in kinase buffer. Following the pre-incubation, 300 ng of recombinant
COMMD4 was added for 30 min at 4 °C. COMMD4 bound to protein A Dyna-
beads (Thermo Fisher Scientific) were used to pull-out the bound complexes. The
beads were subsequently washed several times with high and medium salt buffer,
resuspended in 4X Laemmli sample buffer and immunoblotted with the antibodies
indicated.
Statistics and reproducibility. Data are presented as means and SD or SEM where
shown, from ≥3 independent experiments. Statistical analyses were performed
using a two-tailed non-paired Student’s t test. The level of significance was set at ns
(not significant) p > 0.05, *p < 0.05 and **p < 0.005. No statistical methods were
used to predetermine sample size.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data underlying figures is presented in Supplementary Data 1. Plasmids and other
relevant data are available from the corresponding authors upon reasonable request.
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